Sign In
Free Newsletter
NJ Assembly advances PBM reform bill to cut drug costs
The New Jersey General Assembly advanced a measure that aims to lower prescription drug costs, increase transparency and regulate PBMs in New Jersey's healthcare system.
OPINION: PBMs drive up drug costs for NJ employers
New Jersey Hospital Association President and CEO Cathy Bennett writes New Jersey employers face rising prescription costs as PBMs profit from rebates and spread pricing, raising employee out-of-pocket expenses.
NJ sues Novartis over alleged generic drug price fixing
New Jersey joins a multistate lawsuit accusing Novartis and Sandoz of price fixing 31 generic drugs, raising costs for consumers, Medicare and Medicaid.
NJ pharma firms join Trump drug pricing deals
Four Garden State companies are among the latest to strike agreements with the White House to lower prescription costs under the president's policy.
